查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1722517

不孕症药物市场报告（按药物类别（促性腺激素、芳香化酶抑制剂、选择性雌激素受体调节剂、双胍类等）、给药途径、配销通路、最终用户和地区划分，2025 年至 2033 年）

Infertility Drugs Market Report by Drug Class (Gonadotropin, Aromatase Inhibitors, Selective Estrogen Receptor Modulators, Biguanides, and Others), Route of Administration, Distribution Channel, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球不孕症药物市场规模达 41 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 63 亿美元，2025-2033 年期间的成长率 (CAGR) 为 4.49%。不孕症的上升、辅助生殖技术（ART）的进步、政府的支持措施、医疗支出的增加、新药的开发、保险覆盖的可用性以及生育诊所的激增都是加速市场成长的一些因素。

不孕症药物是指各种用于治疗不孕症和增强个人生殖健康的药物。它们可以注射或口服。一些常用的不孕症药物包括促性腺激素、芳香酶抑制剂、选择性雌激素受体调节剂 (SERM)、双胍类、促排卵剂、多巴胺激动剂和三环类抗忧郁剂。它们透过刺激女性卵巢排卵和卵泡发育发挥作用，而它们有助于恢復男性睪固酮水平并提高精子品质以实现怀孕。近年来，不孕症药物在无法怀孕的夫妇中越来越受欢迎。

不孕不孕药物市场趋势：

不孕症药物透过恢復个人的受孕能力来帮助提高夫妇怀孕的机会。因此，不孕症和流产发生率的上升是推动市场成长的主要因素。除此之外，各国政府为传播有关可用治疗方案的认识而采取的多项有利倡议也刺激了对不孕症药物的需求。此外，由于繁忙的工作日程、随之而来的压力和生活方式的改变，癌症、肥胖、糖尿病、甲状腺、多囊性卵巢症候群（PCOS）和更年期障碍等慢性疾病的盛行率显着增加。同时，由于延迟怀孕、晚婚以及酗酒、吸毒和吸烟等不良习惯导致的生育率下降正在加速产品采用率。此外，一些主要参与者正在进行研发活动，以推出疗效更强、剂量要求更低、副作用更少的创新不孕症药物。此外，用于开发这些药物的公共资金的增加以及各监管机构加快的药物审批速度正在推动市场成长。其他因素，包括对仿製药的需求不断增加、医疗保健基础设施的改善、消费者支出能力的提高、快速的城市化和技术进步，也为市场成长提供了积极的推动力。

本报告回答的关键问题

  • 不孕不育药物市场有多大？不孕不育药物市场的未来前景如何？
  • 推动不孕症药物市场的关键因素有哪些？
  • 哪个地区占据不孕症药物最大的市场份额？
  • 全球不孕症药物市场领先的公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球不孕不育药物市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依药品类别

  • 促性腺激素
  • 芳香化酶抑制剂
  • 选择性雌激素受体调节剂 (SERM)
  • 双胍类
  • 其他的

第七章：市场区隔：依行政途径

  • 口服
  • 静脉
  • 皮下
  • 肌肉注射

第八章：市场区隔：按配销通路

  • 医院药房
  • 零售药局
  • 其他的

第九章：市场区隔：依最终用户

  • 男性
  • 女性

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Bayer AG
    • Ferring Pharmaceuticals
    • Livzon Pharmaceutical Group Inc.
    • Mankind Pharma
    • Merck & Co. Inc.
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
    • Theramex
Product Code: SR112025A5239

The global infertility drugs market size reached USD 4.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.3 Billion by 2033, exhibiting a growth rate (CAGR) of 4.49% during 2025-2033. Increasing infertility rates, advancements in assisted reproductive technologies (ART), supportive government initiatives, rising healthcare expenditure, new pharmaceutical developments, availability of insurance coverage, and the proliferation of fertility clinics are some of the factors accelerating the market growth.

Infertility drugs refer to various medications used to treat infertility and enhance the reproductive health of an individual. They are either injected or taken orally. Some commonly used infertility drugs include gonadotrophins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), biguanides, ovulatory stimulants, dopamine agonists, and tricyclic antidepressants. They work by stimulating ovulation and follicle development of the ovary in women, whereas they help restore testosterone levels and improve the quality of sperm in men to bring about pregnancy. In recent years, infertility drugs have gained traction among couples who are unable to conceive.

Infertility Drugs Market Trends:

Infertility drugs assist in enhancing the chances of pregnancy in couples by restoring the ability of an individual to contribute to conception. As a result, the rising incidences of infertility and miscarriage represents the primary factor driving the market growth. Besides this, several favorable initiatives undertaken by governments of various countries to spread awareness regarding the available treatment options are catalyzing the demand for infertility drugs. Additionally, there has been a significant increase in the prevalence of chronic diseases, such as cancer, obesity, diabetes, thyroid, polycystic ovarian syndrome (PCOS), and menopausal disorders, on account of hectic work schedules, accompanying stress, and lifestyle changes. Along with this, the declining fertility rates due to delayed pregnancies, late marriages, and unhealthy habits, such as excessive consumption of alcohol, drugs, and smoking, are accelerating the product adoption rates. Furthermore, several key players are engaging in research and development (R&D) activities to launch innovative infertility drugs with enhanced efficacy, lower dosage requirements, and fewer side effects. Moreover, the increasing public funding for developing these drugs and faster drug approvals from various regulatory bodies are propelling the market growth. Other factors, including the escalating demand for generic medicines, improving healthcare infrastructure, rising consumer expenditure capacities, rapid urbanization, and technological advancements, are also providing a positive thrust to the market growth.

Key Market Segmentation:

Breakup by Drug Class:

  • Gonadotropin
  • Aromatase Inhibitors
  • Selective Estrogen Receptor Modulators (SERMs)
  • Biguanides
  • Others

Breakup by Route of Administration:

  • Oral
  • Intravenous
  • Subcutaneous
  • Intramuscular

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Breakup by End User:

  • Male
  • Female

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bayer AG, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Inc., Mankind Pharma, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Theramex.

Key Questions Answered in This Report

  • 1.How big is the infertility drugs market?
  • 2.What is the future outlook of infertility drugs market?
  • 3.What are the key factors driving the infertility drugs market?
  • 4.Which region accounts for the largest infertility drugs market share?
  • 5.Which are the leading companies in the global infertility drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Infertility Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Drug Class

  • 6.1 Gonadotropin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Aromatase Inhibitors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Selective Estrogen Receptor Modulators (SERMs)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Biguanides
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Intravenous
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Subcutaneous
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Intramuscular
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Male
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Female
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Ferring Pharmaceuticals
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Livzon Pharmaceutical Group Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Mankind Pharma
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Merck & Co. Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Merck KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Novartis AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Pfizer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Sanofi S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Theramex
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Infertility Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Infertility Drugs Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Infertility Drugs Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Infertility Drugs Market: Breakup by Drug Class (in %), 2024
  • Figure 5: Global: Infertility Drugs Market: Breakup by Route of Administration (in %), 2024
  • Figure 6: Global: Infertility Drugs Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Infertility Drugs Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Infertility Drugs Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Infertility Drugs (Gonadotropin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Infertility Drugs (Gonadotropin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Infertility Drugs (Aromatase Inhibitors) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Infertility Drugs (Aromatase Inhibitors) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Infertility Drugs (Biguanides) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Infertility Drugs (Biguanides) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Infertility Drugs (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Infertility Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Infertility Drugs (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Infertility Drugs (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Infertility Drugs (Intravenous) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Infertility Drugs (Intravenous) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Infertility Drugs (Subcutaneous) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Infertility Drugs (Subcutaneous) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Infertility Drugs (Intramuscular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Infertility Drugs (Intramuscular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Infertility Drugs (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Infertility Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Infertility Drugs (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Infertility Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Infertility Drugs (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Infertility Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Infertility Drugs (Male) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Infertility Drugs (Male) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Infertility Drugs (Female) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Infertility Drugs (Female) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: North America: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: North America: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: United States: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: United States: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Canada: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Canada: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Asia-Pacific: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Asia-Pacific: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: China: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: China: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Japan: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Japan: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: India: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: India: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: South Korea: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: South Korea: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Australia: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Australia: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Indonesia: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Indonesia: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Others: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Others: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Europe: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Europe: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Germany: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Germany: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: France: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: France: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: United Kingdom: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: United Kingdom: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Italy: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Italy: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Spain: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Spain: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Russia: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Russia: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Latin America: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Latin America: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Brazil: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Brazil: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Mexico: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Mexico: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Others: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Others: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Middle East and Africa: Infertility Drugs Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Middle East and Africa: Infertility Drugs Market: Breakup by Country (in %), 2024
  • Figure 85: Middle East and Africa: Infertility Drugs Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 86: Global: Infertility Drugs Industry: SWOT Analysis
  • Figure 87: Global: Infertility Drugs Industry: Value Chain Analysis
  • Figure 88: Global: Infertility Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Infertility Drugs Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Infertility Drugs Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 3: Global: Infertility Drugs Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 4: Global: Infertility Drugs Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Infertility Drugs Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Infertility Drugs Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Infertility Drugs Market: Competitive Structure
  • Table 8: Global: Infertility Drugs Market: Key Players